000			02917nam a2200421 i 4500
999			_c362970 _d362970 _x1
001			362970
003			ES-MaUEC
005			20230102121637.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			211018s2021 sz a s |||| 0|eng d
020			_a9783030785598
024	7		_a10.1007/978-3-030-78559-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM666.C266 _b2021 EB
100	1		_aO'Brien, Kylie _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9682450
245	1	0	_aMedicinal Cannabis and CBD in Mental Healthcare _cby Kylie O'Brien, Philip Blair
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
264		4	_c2021
300			_a1 recurso en línea (XXI, 576 páginas) _bilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_aIntroduction -- Endocannabinoid system -- ECS and regulation of stress -- Overview of cannabis -- Stress and Anxiety.-Depression -- PSTD -- Sleep -- Alzheimers -- Autism -- Conclusion.
520			_aThis book functions as a clinician's guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use. The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies. Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.
988			_aSpringer_Medicine_2021
650		7	_2embne _9262120 _aCannabis _xUso terapéutico
700	1		_aBlair, Philip _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9682451
776	0	8	_iPrinted edition: _z9783030785581
776	0	8	_iPrinted edition: _z9783030785604
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-78559-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _ek _zSI